NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/05/2023
Back to search
Official data from USPTO
BACTIMICINA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
11/05/2023
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
08/19/1992
Registration date
05/18/1993
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/05/2023
Last transaction
11/05/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
08/31/1978
First use in commerce
08/31/1978
Drawing code
1
Owner type
03
Owner location
PARAMOUNT, CA, US
Examiner
MICHOS, JOHN E
Law office
G30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
DLC LABORATORIES, INC.
DLC ENTERPRISES, INC.
Kessaris, Spero
Kessaris, Carmen F.
Representatives
Leonard D. Messinger FULWIDER PATTON LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
throat lozenges
Publications
History of USPTO decisions and trademark events.
25 publications found
RNL3
REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
11/05/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/05/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/04/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
05/11/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/18/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/19/2017
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED
12/15/2012
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
12/15/2012
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/15/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/15/2012
E89R
TEAS SECTION 8 & 9 RECEIVED
11/21/2012
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/20/2012
CFIT
CASE FILE IN TICRS
02/09/2009
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/23/2003
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/23/2003
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
04/25/2003
E89R
TEAS SECTION 8 & 9 RECEIVED
04/24/2003
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/31/1999
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
03/23/1999
R.PR
REGISTERED-PRINCIPAL REGISTER
05/18/1993
PUBO
PUBLISHED FOR OPPOSITION
02/23/1993
NPUB
NOTICE OF PUBLICATION
01/22/1993
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/09/1992
CNEA
EXAMINER'S AMENDMENT MAILED
11/18/1992
Continuous trademark protection
Get notified about every new filing that threatens BACTIMICINA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.